THE EFFECT OF SGLT2 INHIBITOR THERAPY ON THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. scientific. 2026;86(2):148-150. Accessed February 28, 2026. https://journalss.org/index.php/obr/article/view/16527